Patents by Inventor Henri R. Ford

Henri R. Ford has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protective role of semapimod in necrotizing enterocolitis
    Patent number: 8314149
    Abstract: A method is disclosed wherein semapimod, and/or the mesylate salt thereof, is administered for the treatment of necrotizing enterocolitis.
    Type: Grant
    Filed: September 10, 2010
    Date of Patent: November 20, 2012
    Assignees: Feering B.V., University of Pittsburgh—Of The Commonwealth System Of Higher Education
    Inventors: Ruben Zamora, Henri R. Ford, Thais Sielecki-Dzurdz, Vidal F. De La Cruz
  • HMGB1 EXPRESSION AND PROTECTIVE ROLE OF SEMAPIMOD IN NEC
    Publication number: 20110224301
    Abstract: Methods are described, which include the administration of semapimod or guanylhydrazone containing compounds, salt thereof, or a combination of the compound and a salt thereof for the inhibition, treatment, and/or prevention of any of NEC, a condition associated with the release of HMGB1, a condition associated with the release of iNOS protein, a condition associated with the release of Bax protein, a condition associated with the release of Bad protein, a condition associated with the release of COX-2 protein, or a condition associated with the release of RAGE, or a combination thereof to a subject in need thereof.
    Type: Application
    Filed: September 10, 2010
    Publication date: September 15, 2011
    Applicant: CYTOKINE PHARMASCIENCES, INC.
    Inventors: Ruben ZAMORA, Henri R. FORD, Thais SIELECKI-DZURDZ, Vidal F. DE LA CRUZ
  • Protective role of semapimod in necrotizing enterocolitis
    Patent number: 7795314
    Abstract: A method is described wherein semapimod is administered, or a salt thereof, or a combination of semapimod and a salt thereof, for the treatment of necrotizing enterocolitis.
    Type: Grant
    Filed: June 1, 2006
    Date of Patent: September 14, 2010
    Assignee: Cytokine PharmaSciences, Inc.
    Inventors: Ruben Zamora, Henri R. Ford, Thais Sielecki-Dzurdz, Vidal F. De La Cruz